|
Dr. Cresswell is the former Senior Vice President and Chief Scientific Officer of Warner-Lambert. He began his tenure with Warner-Lambert in 1988 as the President of Research and Development of the Parke-Davis Pharmaceutical Research Division. From 1989-1998, he served as Vice President and Chairman of the Parke-Davis Worldwide Pharmaceutical Research Division. Dr. Cresswell's vision and leadership in the development of Lipitor® at Parke-Davis was instrumental in the product's ultimate success. Dr. Cresswell joined Warner-Lambert from Laporte Industries, Ltd., an international chemical company, where he was Chief Operating Officer. Prior to this, Dr. Cresswell was with Burroughs Wellcome for over twenty years. At Burroughs Wellcome, he held a broad range of research and development positions in both the United Kingdom and the United States, and was responsible for a research staff of over 3,000 people. Dr. Cresswell has served on the Board of Directors of Esperion Therapeutics, Inc., Allergan, Inc., and Curagen Corporation. Dr. Cresswell joined Vasogen's Board in 2006. | 